Literature DB >> 31686359

Incidence and implications of acute kidney injury in patients hospitalized with acute decompensated heart failure.

Rajkumar Doshi1, Tania Dhawan2, Casey Rendon2, Marines Acevedo Rodriguez2, Jaafar F Al-Khafaji2, Mohamed Taha2, Thi Thi Win2, Nageshwara Gullapalli2.   

Abstract

Acute kidney injury (AKI) is a common complication in patients hospitalized with heart failure (HF). There is a paucity of research on the incidence and consequences of AKI among patients hospitalized with HF who do not have evidence of chronic kidney disease (CKD). The National Inpatient Sample database was used to identify index hospitalizations for acute HF from January 2012 through September 2015. The incidence of new-onset AKI was determined, and the study population was divided into two groups: HF with AKI (HFwAKI) and HF without AKI (HFwoAKI). These groups were further divided into the subgroups HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). A total of 2,010,095 index hospitalizations for HF were identified. The incidence of new-onset AKI was found to be ~ 20% for this population. In a fully adjusted model, in-hospital mortality was higher in the HFwAKI group (adjusted OR 3.63, P ≤ 0.001) and higher among patients with HFrEF (adjusted OR 3.85), as opposed to patients with HFpEF (adjusted OR 3.21). Similarly, length of stay and cost of care for the HFwAKI group were significantly higher as well. New-onset AKI among hospitalizations for HF poses a significant health problem, especially considering the increasing prevalence of HF. Further research into the causes of AKI among HF hospitalizations is, therefore, important as it will enable the development of treatment strategies to prevent AKI in HF hospitalizations and, consequently, benefit both the patients and health care system of the United States.

Entities:  

Keywords:  Heart failure; In-hospital mortality; Incidence; New-onset acute kidney injury

Year:  2019        PMID: 31686359     DOI: 10.1007/s11739-019-02188-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  29 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

2.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

3.  Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.

Authors:  Si-Hyuck Kang; Jin Joo Park; Dong-Ju Choi; Chang-Hwan Yoon; Il-Young Oh; Seok-Min Kang; Byung-Su Yoo; Eun-Seok Jeon; Jae-Joong Kim; Myeong-Chan Cho; Shung Chull Chae; Kyu-Hyung Ryu; Byung-Hee Oh
Journal:  Heart       Date:  2015-08-28       Impact factor: 5.994

4.  Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

Authors:  Sushrut S Waikar; Ron Wald; Glenn M Chertow; Gary C Curhan; Wolfgang C Winkelmayer; Orfeas Liangos; Marie-Anne Sosa; Bertrand L Jaber
Journal:  J Am Soc Nephrol       Date:  2006-04-26       Impact factor: 10.121

5.  Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.

Authors:  Nirav Patel; Rajat Kalra; Rajkumar Doshi; Navkaranbir S Bajaj; Garima Arora; Pankaj Arora
Journal:  JACC Heart Fail       Date:  2018-05       Impact factor: 12.035

6.  In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals.

Authors:  Nirav Patel; Ankur Gupta; Rajkumar Doshi; Rajat Kalra; Navkaranbir S Bajaj; Garima Arora; Pankaj Arora
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-01

7.  Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations.

Authors:  Sean M Bagshaw; Eric A Hoste; Branko Braam; Carlo Briguori; John A Kellum; Peter A McCullough; Claudio Ronco
Journal:  Contrib Nephrol       Date:  2013-05-13       Impact factor: 1.580

Review 8.  Distant Organ Dysfunction in Acute Kidney Injury: A Review.

Authors:  Sul A Lee; Martina Cozzi; Errol L Bush; Hamid Rabb
Journal:  Am J Kidney Dis       Date:  2018-06-14       Impact factor: 8.860

9.  Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.

Authors:  Parag Goyal; Zaid I Almarzooq; Evelyn M Horn; Maria G Karas; Irina Sobol; Rajesh V Swaminathan; Dmitriy N Feldman; Robert M Minutello; Harsimran S Singh; Geoffrey W Bergman; S Chiu Wong; Luke K Kim
Journal:  Am J Med       Date:  2016-06       Impact factor: 4.965

10.  Evaluation of the Incidence of New-Onset Atrial Fibrillation After Aortic Valve Replacement.

Authors:  Rajat Kalra; Nirav Patel; Rajkumar Doshi; Garima Arora; Pankaj Arora
Journal:  JAMA Intern Med       Date:  2019-08-01       Impact factor: 21.873

View more
  3 in total

Review 1.  A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).

Authors:  Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

2.  Development and Validation of a Prediction Model for Irreversible Worsened Cardiac Function in Patients With Acute Decompensated Heart Failure.

Authors:  Lei Wang; Yun-Tao Zhao
Journal:  Front Cardiovasc Med       Date:  2021-12-10

3.  Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.

Authors:  Ming-Jen Chan; Yung-Chang Chen; Pei-Chun Fan; Cheng-Chia Lee; George Kou; Chih-Hsiang Chang
Journal:  Biomedicines       Date:  2022-03-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.